darnatein
We create superagonists to cure patients better than Mother Nature. Design-Augmented (DA) RNA and protein biotherapeutics, such as DaRT101 and DaRT102, are being tested at darnatein to cure age-related disorders in the spine and joint cartilage. Current regimens available to patients with spine and joint cartilage disorders are conducted either by surgery or pain-managing NSAID drugs. DaRT101 provides a new mechanism of action as a potential DMOAD (Disease-Modifying Osteoarthritis Drug).
Our body’s aging process is bound by a natural set of signals and genes that make up our genetic codes. Our scientific strategy at darnatein is to restore the balance of the signals between agonists and antagonists in the body. Certain agonist signals, for instance, those that maintain healthy cartilage, decrease naturally as we age. By creating super-agonists involved in tissue regeneration, we can overcome such natural barriers.
We discovered that these DA biotherapeutics can regenerate and cure better than Mother Nature.
Contact us at darnatein@gmail.com for further inquiries.